Literature DB >> 15610668

Malaria Vaccine Trial: Modest Protection, Good Progress.

Mary E Wilson.   

Abstract

Entities:  

Year:  2005        PMID： 15610668     DOI： 10.1007/s11908-005-0020-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  5 in total

1.  Vaccine efficacy: winning a battle (not war) against malaria.

Authors:  Philippe Van de Perre; Jean-Pierre Dedet
Journal:  Lancet       Date:  2004 Oct 16-22       Impact factor: 79.321

2.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Authors:  K A Bojang; P J Milligan; M Pinder; L Vigneron; A Alloueche; K E Kester; W R Ballou; D J Conway; W H Reece; P Gothard; L Yamuah; M Delchambre; G Voss; B M Greenwood; A Hill; K P McAdam; N Tornieporth; J D Cohen; T Doherty
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

Review 3.  Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

Authors:  Joel G Breman; Martin S Alilio; Anne Mills
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

4.  Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali.

Authors:  Kirsten E Lyke; Alassane Dicko; Abdoulaye Kone; Drissa Coulibaly; Ando Guindo; Yacouba Cissoko; Karim Traoré; Christopher V Plowe; Ogobara K Doumbo
Journal:  Vaccine       Date:  2004-08-13       Impact factor: 3.641

Review 5.  The global distribution and population at risk of malaria: past, present, and future.

Authors:  Simon I Hay; Carlos A Guerra; Andrew J Tatem; Abdisalan M Noor; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.